Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide for Methamphetamine Use Disorder
NCT07825857Phase 2Recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Oct 2026
- Primary completion
- Jul 2031
- Countries
- 1
01
Overview
A Phase 2 trial of tirzepatide in methamphetamine use disorder (MUD), sponsored by UT Southwestern Medical Center. Started Oct 2026; status: recruiting.
02
Drugs
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT07825857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07825857.